CDPHE: Providers can administer Pfizer COVID-19 vaccine to Coloradans age 12+

Providers in Colorado who are administering the Pfizer COVID-19 vaccine can now vaccinate any Coloradan age 12 and up who wants the vaccine. 

Minors under the age of 18 who wish to receive a COVID-19 vaccine need parental consent. Parents do not need to be present for the vaccination as long as consent is documented, but they should check with the vaccine provider to confirm. The state’s vaccine provider map includes information on which vaccine each location is administering. All of the state’s Community Vaccination Sites offer the Pfizer vaccine, and most do not require an appointment.

“We are excited to hear that we are able to offer this safe and effective vaccine to nearly 300,000 additional Coloradans between the ages of 12 and 15,” said Dr. Alexis Burakoff, a medical epidemiologist at CDPHE. “As more older Coloradans have accessed the vaccine, we are seeing higher rates of cases in teenagers and children. We know there is a clear correlation between high vaccination rates and low infection rates, and this vaccine can now provide relief for thousands of additional families across the state.”

Schools, childcare, and higher education account for the highest proportion of newly reported outbreaks currently.

The state will adjust the COVID-19 data dashboard to include all Coloradans ages 12 and up in the vaccine-eligible population when the website updates at 4 p.m., Thursday, May 13. This will add 299,206 Coloradans to the statewide and county populations used to determine county-level vaccination rates on the vaccine data dashboard, so vaccination rates will appear to temporarily decline. 

On Monday, the FDA announced an amendment to the emergency use authorization for Pfizer’s COVID-19 vaccine to include children ages 12-15. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices met today and approved the use of the Pfizer vaccine in this younger population. In a clinical trial, the Pfizer vaccine was shown to be safe and effective among people ages 12-15. The trial included 2,260 children ages 12-15 years old in the U.S. There were 18 cases of COVID-19 in the placebo (unvaccinated) group and none in the vaccinated group. The vaccine showed 100% efficacy in this trial.

There were no severe adverse events clearly associated with the vaccine in the trial. Side effects of the vaccine in this age group were similar to those seen among young adults (e.g., temporary sore arm, fatigue, headache, chills, muscle aches). CDC and FDA will continue monitoring for safety. 

The Moderna and Janssen (Johnson & Johnson) vaccines continue to be available only to adults 18 years of age and older.

Continue to stay up to date by visiting covid19.colorado.gov.

CDPHE: Providers can administer Pfizer COVID-19 vaccine to Coloradans age 12+

CDPHE: State adds 2,360 additional sequence-confirmed variants to COVID-19 data dashboard

These confirmed variant cases do not represent new cases

May 11, 2021 – Today, the state completed processing large batches of sequencing results, adding a total of 2,360 additional variants of concern and variants under investigation to the data dashboard as part of an update spanning several days.

Variants of concern do not represent a new case of COVID-19 in the state, as sequencing is conducted only on positive tests that have already been accounted for in the state’s case totals. Variant cases now make up more than half of all new cases in the state. If you contract COVID today, it is more likely than not that you were exposed to and have contracted a variant strain.

Getting vaccinated provides the greatest protection against COVID-19 and variants. Colorado county-level data shows a clear correlation between high vaccination rates and low infection rates. We’re starting to see population-level protection from these vaccines resulting in decreased transmission, but we still have a ways to go.

CDPHE is consistently working to update sequencing information and other data in our databases as close to real time as possible. Large-scale population-based sequencing allows us to understand the proportions of variants circulating within our population. 

Continue to stay up to date by visiting covid19.colorado.gov.

CDPHE: State adds 2,360 additional sequence-confirmed variants to COVID-19 data dashboard

CDPHE: Colorado resumes use of Johnson & Johnson vaccine to help end the pandemic

In response to the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) announcement that providers should resume using the Johnson & Johnson vaccine, the Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers they can proceed with using the Janssen (Johnson & Johnson) COVID-19 vaccine immediately.

“We are happy to have this highly effective, one-dose vaccine back as an option for Coloradans,” said Dr. Eric France, CDPHE chief medical officer. “We appreciate the caution the CDC and FDA took to evaluate the Johnson & Johnson vaccine and are ready to ramp back up distribution as quickly as possible.”

The ACIP’s recommendation comes after federal health officials recommended temporarily suspending use of the vaccine after reviewing reports of six individuals in the U.S. who got rare and severe blood clots after receiving the vaccine (now called thrombosis with thrombocytopenia syndrome or TTS). In light of today’s news, CDPHE has decided to proceed by including FDA’s updated warning to patients about the increased risk of very rare but potentially severe TTS, particularly among women under the age of 50 (approximately 7 cases of TTS per 1,000,000 vaccine doses have been identified in this group to date). CDPHE has also sent information to health care providers to inform how to identify and treat TTS in the very rare case it were to occur. 

According to a press release from the FDA and CDC, the two agencies have determined the following:

  • Use of the Janssen COVID-19 Vaccine should be resumed in the United States.
  • The FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19.
  • The FDA has determined that the available data show that the vaccine’s known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older.
  • At this time, the available data suggest that the chance of TTS occurring is very low, but the FDA and CDC will remain vigilant in continuing to investigate this risk.
  • Health care providers administering the vaccine and vaccine recipients or caregivers should review the Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Fact Sheet for Recipients and Caregivers, which have been revised to include information about the risk of this syndrome, which has occurred in a very small number of people who have received the Janssen COVID-19 Vaccine.

“Vaccine safety and the health and safety of all Coloradans is a top priority,” Dr. France added. “The CDC and FDA conducted this investigation and review out of an abundance of caution and is a result of their long-standing and ongoing safety monitoring processes of all vaccines.”

Vaccine providers are required to report any adverse events following COVID-19 vaccination to the Vaccine Adverse Event Reporting System

The CDC’s v-safe is a new smartphone-based, after-vaccination health checker for people who receive COVID-19 vaccines. When you receive your vaccine, you should also receive a v-safe information sheet telling you how to enroll in v-safe. If you enroll, you will receive regular text messages directing you to surveys where you can report any problems or adverse reactions you have after receiving a COVID-19 vaccine. V-safe is available in English, Korean, simplified Chinese, Spanish, and Vietnamese.

All Coloradans over the age of 16 who want a vaccine can get one. The vaccines will help us get back to work, back to spending time with friends and family, and back to a more normal life. None of the currently authorized vaccines is currently recommended over any other. All three vaccines are safe and work well to prevent moderate to severe COVID-19 disease. For more information about COVID-19 vaccines, please visit CDPHE’s vaccine webpage.

Additional Resources from the CDC and FDA:

Continue to stay up to date by visiting covid19.colorado.gov.

CDPHE: Colorado resumes use of Johnson & Johnson vaccine to help end the pandemic

CDPHE: Colorado pauses use of Johnson & Johnson COVID-19 vaccine after joint FDA and CDC announcement

In response to the joint CDC and FDA announcement and out of an abundance of caution, today the Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers to temporarily pause use of the Johnson & Johnson (Janssen) COVID-19 vaccine. 

Federal health officials recommended temporarily suspending use of the vaccine after reviewing reports of six individuals in the U.S. who got rare and severe blood clots after receiving the vaccine. The federal government is allowing states to determine whether to pause use, and CDPHE is requiring providers to stop administration of the Johnson & Johnson (Janssen) vaccine until additional information becomes available. One of the reasons the FDA and CDC are recommending this pause is to ensure health care providers are aware of these potential but rare adverse events and can respond accordingly. The treatment for these types of blood clots is not the common treatment and thus time is needed to make sure healthcare providers know how to recognize and treat these rare occurrences. 

COVID-19 vaccine safety and the health and safety of all Coloradans is a top priority. These adverse events appear to be extremely rare. Individuals who received the Johnson & Johnson (Janssen) vaccine more than a month ago are at very low risk of serious side effects. Anyone who received the Johnson & Johnson (Janssen) vaccine within the last three weeks and who develops severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider. These symptoms are different from the flu-like symptoms people may experience after receiving a COVID-19 vaccine. Healthcare providers should report any adverse events to the Vaccine Adverse Event Reporting System (VAERS).

“In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the FDA and CDC stated in a joint statement.  

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will hold an emergency meeting Wednesday, April 14, to further review the cases and assess their potential significance, and the Food and Drug Administration will continue to investigate. The state will share additional information on how this affects Coloradans as soon as it becomes available. 

The Johnson & Johnson (Janssen) vaccine makes up only a small portion of Colorado’s weekly vaccine allocation. This week, for example, the state’s Johnson & Johnson (Janssen) allocation is 9,700, compared to nearly 280,000 doses of Pfizer and Moderna the state expects to receive this week. Most vaccine clinics will not be significantly affected. 

Anyone scheduled to receive the Johnson & Johnson (Janssen) vaccine will either receive the Pfizer or Moderna vaccine instead, or the vaccine provider will contact them to reschedule their appointment once FDA and CDC release additional information. 

The state’s mobile vaccination buses, which have been administering only the Johnson & Johnson (Janssen) vaccine, are canceled today and Wednesday. More information will be provided when it becomes available. 

Providers who already have a Johnson & Johnson (Janssen) vaccine supply should keep it and continue to maintain proper storage

Continue to stay up to date by visiting covid19.colorado.gov.

CDPHE: Colorado pauses use of Johnson & Johnson COVID-19 vaccine after joint FDA and CDC announcement

CDPHE: State adds percentage of residents vaccinated by county to vaccine data dashboard

The state has updated its COVID-19 vaccine data dashboard to reflect the percentage of residents at least partially vaccinated or fully vaccinated by county. This new data supplements current county level data regarding doses distributed and doses administered to provide a more comprehensive snapshot of vaccination progress by county.

The two new data tabs and their definitions are:

1+ Vaccination Rate: the percentage of people who have received at least one dose of any COVID-19 vaccine. This includes people who have received at least one dose of Pfizer, Moderna, or Janssen (Johnson & Johnson) vaccine. If an individual has received more than one dose, they will also be counted in the Up-to-Date Vaccination Rate. This data is based on the immunized person’s county of residence as listed in the Colorado Immunization Information System (CIIS).

Up-to-Date Vaccination Rate: the percentage of people who have received at least two doses of either Pfizer or Moderna vaccine, or who have received at least one dose of Janssen (Johnson & Johnson) vaccine. Any individual with a second dose administered on a different day than the initial dose will be counted as receiving two doses. These individuals are also counted in the 1+ Vaccination Rate data. This data is based on the immunized person’s county of residence as listed in the Colorado Immunization Information System (CIIS). 

Continue to stay up to date by visiting covid19.colorado.gov.

____________________________________________________________________________________

El estado añade porcentaje de residentes vacunados por condado, al tablero de datos de vacunas

REMOTO, (8 de abril de 2021): Hoy, el estado actualizó su tablero de datos de vacunas del COVID-19 para reflejar el porcentaje de residentes por condado que al menos fueron parcialmente vacunados o fueron completamente vacunados. Estos datos nuevos complementan los datos  actuales  de los condados con respecto a dosis distribuidas y dosis administradas para proveer un resumen más comprensible del progreso de vacunación por condado. 

Los dos tabuladores nuevos de datos y sus definiciones son:

1+ Índice de Vacunación: el porcentaje de personas que han recibido al menos una dosis de cualquiera de las vacunas contra el COVID-19. Esto incluye personas que han recibido al menos una dosis de las vacunas Pfizer, Moderna, o Janssen (Johnson & Johnson). Si un individuo ha recibido más de una dosis, será contado en el Índice de Vacunación Actual. Estos datos están basados en el condado de residencia de la persona inmunizada según está inscrito en el Sistema de Información de Inmunización de Colorado (CIIS, según sus siglas en inglés). 

Resumen Actualizado de Vacunación: el porcentaje de personas que han recibido al menos dos dosis de la vacuna Pfizer o de Moderna, o que han recibido al menos una dosis de la vacuna Janssen (Johnson & Johnson). Cualquier individuo que haya sido administrado con una segunda dosis en un día diferente a la dosis inicial será contado como si hubiera recibido dos dosis. Estos individuos también serán contados en el 1+ Índice de Vacunación. Estos datos están basados en el condado de residencia de la persona inmunizada según está registrado en el  Sistema de Información de Inmunización de Colorado (CIIS, según sus siglas en inglés). 

Continúe manteniéndose al día visitando covid19.colorado.gov

CDPHE: State adds percentage of residents vaccinated by county to vaccine data dashboard

CDPHE: COVID-19 P.1 variant detected in Colorado

The Centers for Disease Control and Response (CDC) have notified the Colorado Department of Public Health and Environment (CDPHE) of its first COVID-19 P.1 variant cases (2) in Colorado. Public health officials originally identified the P.1 variant among travelers from Brazil arriving in Japan. This is the first detection of P.1 in the state, but to date 289 cases have been identified across 25 jurisdictions in the U.S. The variant cases are residents of Boulder county. Prior travel history for both individuals is unknown at this time. CDPHE is investigating possible exposures and performing contact tracing to determine if the variant virus has spread to others. Boulder County Public Health is working closely with CDPHE to provide local support if needed or requested. 

Coloradans should continue to wear masks, practice physical distancing, wash their hands frequently, and get vaccinated when it is their turn. These are our best tools for preventing the spread of this virus, no matter the strain. Early research suggests that the currently authorized vaccines are effective against known variants, though perhaps to varying degrees depending on the strain. Experts stress that getting vaccinated can provide significant protection against transmission and severe illness from COVID-19. 

Continue to stay up to date by visiting covid19.colorado.gov. All detected variants in Colorado are listed on the data dashboard and the CDC has a webpage dedicated to COVID-19 variants.

______________________________________________________________________________________________

CDPHE: Se detectó la variante P.1 del COVID-19 en Colorado

REMOTO, (6 de abril de 2021): Los Centros para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) han notificado al Departamento de Salud Pública y Medio Ambiente de Colorado (CDPHE, por sus siglas en inglés) sobre sus primeros (2) casos de la variante P.1 del COVID-19 en Colorado. Los funcionarios de salud pública identificaron originalmente la variante P.1 entre personas viajando desde Brasil hacia Japón. Esta es la primera detección de P.1 en el estado, pero hasta la fecha se han identificado 289 casos en 25 jurisdicciones en los EE.UU. Los casos de la variante son residentes del condado Boulder. Por ahora se desconoce el historial de viaje de ambas personas. El CDPHE está investigando las posibles exposiciones y realizando rastreo de contactos para determinar si la variante del virus se ha propagado a otras personas. La agencia de Salud Pública del Condado Boulder está trabajando de cerca con el CDPHE para brindar apoyo local, si es necesario o solicitado. 

Los habitantes de Colorado deben continuar usando tapabocas, practicar el distanciamiento físico, lavarse las manos con frecuencia y vacunarse cuando sea su turno. Estas son nuestras mejores herramientas para prevenir la propagación de este virus, sin importar la cepa. Las primeras investigaciones sugieren que las vacunas actualmente autorizadas son eficaces contra las variantes conocidas, aunque quizás en diferentes grados dependiendo de la cepa. Los expertos enfatizan que vacunarse puede proporcionar una protección significativa contra la transmisión y la enfermedad grave del COVID-19. 

Continúe manteniéndose informado visitando covid19.colorado.gov. Todas las variantes detectadas en Colorado aparecen en el tablero de datos y los CDC tienen un sitio web dedicado a las variantes del COVID-19.

CDPHE: COVID-19 P.1 variant detected in Colorado

CDPHE: State updates public health order

Colorado Department of Public Health and Environment (CDPHE) released an amended public health order that provides updates to the COVID-19 dial framework.

Some key changes include:

  • Clarifying that 6 feet distancing from non-household members remains required in Level Green.
  • Specifying that only unseated, rather than seated, Indoor Events are subject to the 50% capacity limit not to exceed 500 people in Level Green.
  • Authorizing counties in Level Green to determine masks requirements as authorized in Executive Order D 2021 079.
  • Authorizing seated Indoor Events in Level Green to operate at 100% capacity with 6 feet distancing, allowing seating of up to 10 people together including non-household members, and requiring organizers or operators of any such events that exceed 500 people to consult with CDPHE.
  • Updating to allow seated Indoor Events in Level Blue to seat up to 10 people together including non-household members, and require organizers or operators of any such events that exceed 500 people to consult with CDPHE.
  • Clarifying that Bars in Level Blue may operate and are not required to sell or provide food.
  • Removing the prohibition on dance floors and games in Restaurants and Bars.

Read a full summary of changes, and review the updated capacity charts in English and Spanish

Continue to stay up to date by visiting covid19.colorado.gov.

_____________________________________________________________________________________________

El Estado actualiza orden de salud pública 

REMOTO, (5 de abril de 2021): El Departamento de Salud Pública y Medio Ambiente de Colorado (CDPHE, por sus siglas en inglés) publicó una orden de salud pública modificada que proporciona actualizaciones para el Sistema de Indicadores del COVID-19.

Algunos cambios clave incluyen:

  • Aclarar que el distanciamiento de 6 pies entre miembros que no son de una misma vivienda sigue siendo requerido en el Nivel Verde.
  • Especificar que solamente los Eventos en Ambientes Cerrados sin asientos, en lugar de con asientos, están sujetos al límite de capacidad del 50% sin exceder 500 personas en el Nivel Verde.
  • Autorizar a los condados en el Nivel Verde a determinar los requisitos del uso de tapabocas, tal como se autoriza en la Orden Ejecutiva D 2021 079.
  • Autorizar que los Eventos en Ambientes Cerrados con asientos en el Nivel Verde operen al 100% de su capacidad con un distanciamiento de 6 pies, permitiendo que se sienten hasta 10 personas juntas, incluyendo a personas que no son miembros de una misma vivienda, y se exige que los organizadores u operadores de cualquier evento de este tipo que exceda las 500 personas consulten con el CDPHE.
  • Actualizar para permitir que en los Eventos en Ambientes Cerrados con asientos en el Nivel Azul se puedan sentar hasta 10 personas juntas, incluyendo a personas que no son miembros de una misma vivienda, y se exige que los organizadores u operadores de cualquier evento de este tipo que supere las 500 personas consulten con el CDPHE.
  • Aclarar que los bares en el Nivel Azul pueden operar, y no están obligados a vender o proporcionar comida.
  • Eliminar la prohibición de las pistas de baile y los juegos en los restaurantes y bares.

Lea un resumen completo de los cambios y revise las tablas de capacidad actualizadas en inglés y español. Continúe manteniéndose informado visitando covid19.colorado.gov.

CDPHE: State updates public health order

CDPHE: More than one million Coloradans are fully vaccinated

Colorado is proud to announce, in collaboration with more than 1100 vaccine providers, the state has reached the one million mark of people fully vaccinated against the COVID-19 virus. The milestone came yesterday as the state moves into Phase 2 of vaccine distribution tomorrow.

“It’s great news to reach this milestone,” said Scott Sherman, Brigadier General, CO Nat. Guard and director of the UCC Vaccine Joint Task Force. “Each vaccine is a step toward getting back to normal — but we can’t stop now. We are focused on ensuring that every Coloradan who wants a vaccine will be able to receive the first dose by the end of May.” 

All Coloradans over the age of 16 who want a vaccine can get one starting Friday. The state has launched six community vaccination clinics across the state to help with vaccine administration and access. Our website has sign up information for these clinics and providers throughout the state. 

Continue to stay up to date by visiting covid19.colorado.gov.

_________________________________________________________________________________________________

Más de un millón de habitantes de Colorado están totalmente vacunados

REMOTO, (1 de abril de 2021): Colorado se enorgullece de anunciar, en colaboración con más de 1,100 proveedores de vacunas, que el estado ha alcanzado la marca de un millón de personas totalmente vacunadas contra el virus COVID-19. El logro se alcanzó ayer, mientras que mañana el estado pasa a la Fase 2 de distribución de la vacuna.

“Alcanzar esta meta es una gran noticia”, dijo Scott Sherman, General de Brigada de la Guardia Nacional de Colorado y director del Grupo de Trabajo Conjunto de la Vacuna UCC. “Cada vacuna es un paso de regreso a la normalidad – pero no podemos detenernos ahora. Estamos enfocados en asegurar que cada habitante de Colorado que quiera una vacuna pueda recibir la primera dosis para fines de mayo.”

Todos los habitantes de Colorado mayores de 16 años que quieran una vacuna podrán recibirla a partir del viernes. El estado ha lanzado seis clínicas comunitarias de vacunación en todo el estado para ayudar con el acceso y la administración de la vacuna. Nuestro sitio web tiene información de inscripción para estas clínicas y proveedores en todo el estado.

 Continúe manteniéndose informado visitando covid19.colorado.gov.

CDPHE: More than one million Coloradans are fully vaccinated

CDPHE: State reminds Coloradans to get tested if experiencing symptoms

Colorado Department of Public Health and Environment (CDPHE) is reminding Coloradans that if they are experiencing COVID-19 symptoms, or believe they may have been exposed, they should get tested for COVID-19. 

Anyone with symptoms should get tested as soon as possible, stay away from others, and follow the instructions on how to isolate. If you think you have been exposed to COVID-19, wait until at least 5 days have passed since the date you think you were last exposed before getting tested, unless you develop symptoms. Follow the instructions on how to quarantine after exposure to prevent further transmission.  

As has been the national trend, the state has seen COVID-19 testing numbers decreasing. 

“While it is good news that more of the state is opening and cases are decreasing, we cannot completely let our guard down or stop using preventive measures until everyone who wants a vaccine has received one,” said Eric France, chief medical officer, CDPHE. “Testing allows the state to monitor the spread of COVID-19 and helps us mitigate outbreaks and increased disease transmission.”

Community testing sites can be found on the state’s website. More information on what to expect when you get tested, what to do if you test positive, the different types of tests, and more are also listed on the website.  

In addition, many counties or providers may have other options, as well. 

Continue to stay up to date by visiting covid19.colorado.gov.

_______________________________________________________________________________________________

El estado le recuerda a los habitantes de Colorado a hacerse una prueba de detección si tienen síntomas del COVID-19.

REMOTO, (30 de marzo,2021): El Departamento de Salud Pública y Medio Ambiente de Colorado (CDPHE, por sus siglas en inglés) le está recordado a los habitantes de Colorado que si tienen síntomas del COVID-19 o creen que han sido expuestos, deberían hacerse una prueba de detección.

Cualquier persona con síntomas debería realizarse la prueba lo antes posible, alejarse de otros y seguir con las indicaciones sobre cómo aislarse. Si cree que ha sido expuesto al COVID-19, espere al menos hasta que hayan pasado 5 días desde la fecha que cree que fue expuesto por última vez antes de realizar la prueba, a no ser que desarrolle síntomas. Siga las indicaciones sobre cómo hacer la cuarentena luego de haber sido expuesto para prevenir con la propagación del virus. 

Al igual que la tendencia nacional, el estado ha visto un decrecimiento en el número de pruebas del COVID-19. 

“Si bien son buenas noticias que el estado está levantando más restricciones y los casos están en declive, no podemos bajar la guardia o dejar de usar las medidas preventivas hasta que todas las personas que quieren recibir la vacuna la hayan recibido”, dijo Eric France, director médico del CDPHE. “La realización de pruebas permite que el estado pueda monitorear la transmisión del COVID-19 y nos ayuda mitigar con los brotes y el aumento de la transmisión. 

Los centros comunitarios se pueden encontrar en el sitio web del estado. Más información sobre qué esperar cuando se realice la prueba de detección, qué hacer si resulta positivo, los diferentes tipos de pruebas de detección y más, se puede encontrar en el sitio web

Además, muchos condados o proveedores pueden tener otras opciones. 

Continúe manteniéndose informado visitando covid19.colorado.gov.

CDPHE: State reminds Coloradans to get tested if experiencing symptoms

CDPHE: New survey shows twice as many Coloradans intend to get a COVID-19 vaccine as last year

Today, Colorado Department of Public Health and Environment (CDPHE) is releasing an updated vaccine opinion survey. Comparing this survey to a previous survey’s data from September 2020, it is clear that there has been a significant shift in Coloradans’ views of the COVID-19 vaccines.

The survey’s key highlights include a significant shift in the percent of Coloradans interested in getting vaccinated when one is available, with 88% of Coloradans now indicating they would possibly be vaccinated, up from 66% in September:

  • In September, 32% of respondents said they intended to get vaccinated as soon as they could. Now, 62% of Coloradans have either already gotten vaccinated (27%), or intend to get vaccinated “as soon as [they] can (35%).”
  • In September, 34% of respondents said they would “wait and see” how well the vaccines worked. Today, only 18% say they want to “wait and see.”
  • In September, 34% of respondents said they would “not get vaccinated.” Now, 8% would “get it, but only if required,” while 12% would “definitely not get it,” including those who are medically unable to do so.
  • Additionally, the data shows significant shifts among specific communities, including:
    • Hispanic women: In September, 22% said they would get vaccinated “as soon as possible.” Now, 43% have already received a vaccine or would get vaccinated as soon as possible.
    • Hispanic men: In September, 35% said they would get vaccinated as soon as possible, as compared to 62% today.
    • Black Coloradans: In September, 24% said they would get vaccinated as soon as possible, as compared to 47% today.
    • Young Coloradans age 18-34: In September, 23% of young women said they would get vaccinated as soon as possible, as compared to 46% today. Young men went from 32% in September to 50% today.

“The COVID-19 vaccines are safe and effective as evidenced not only by clinical trials, but nationally, many millions have already received the vaccine,” said Jill Hunsaker Ryan, executive director, CDPHE. “Hundreds of thousands of Coloradans have already signed up for their vaccine appointments. As more and more Coloradans are getting vaccinated and more and more Coloradans are excited to get vaccinated, we are that much closer to getting back to work and school, back to spending time with family, and back to a more normal life.” 

The survey data is clear; even with this progress, it is important to continue to stress the proven safety and effectiveness of the COVID-19 vaccines. Nearly half (46%) of Coloradans have questions about if the vaccine will protect them, and 42% have questions about why the vaccine is safe.

As part of Governor Polis’ Vaccines for All efforts the state continues to work to increase access to vaccines and to meet Coloradans where they are by:

  • Coordinating community clinics that serve highly impacted communities in more than 30 counties, as well as throughout the Denver metro area, with plans for more. The goal is to vaccinate 70% of eligible residents in communities that are in the top census tracts that have a high density of low-income and minority communities. The state is working directly with community-based organizations, providers, local public health agencies, and Tribes to set up events and ship doses directly to providers in these census tracts in the pursuit of the Governor’s goal to offer life-saving vaccines to everyone that wants it.
  • Launching Community Vaccination Sites in Larimer county, Pueblo, Colorado Springs, Commerce City, and Grand Junction. There will be an additional site coming online in Denver County at the Ball Arena in the coming weeks. The six Vaccines for All community vaccination sites are expected to administer a maximum of 6,000 doses per day at each site at six days per week for a total of 36,000 doses administered each week through the program. This depends on vaccine supply provided to the state.  
  • Coordinating with United Way 211 and transportation providers to assist Coloradans with mobility barriers or without personal vehicles. We are also working with the Colorado Department of Health Care Policy and Financing to identify homebound persons that are unable to attend a vaccine clinic even with transportation support. In these instances, we are working with providers who can go to a person’s home to provide vaccination.
  • Facilitating a Champions for Vaccine Equity program to provide information to communities of color about the safety and efficacy of vaccines, as well as utilizing Promotoras, service providers, and crisis counselors to support vaccine literacy. The initiative is intended to foster sustained dialogue with structurally marginalized communities, particularly communities of color, about the vaccine by connecting them with health care workers from their communities and backgrounds.
  • Launching a 7 day a week, 24-hour hotline that is available to answer questions in multiple languages. The toll-free number is 1-877-CO VAX CO (1-877-268-2926).

Kupersmit Research conducted the survey from February 17 to March 1, 2021, interviewing 810 participants online. The firm conducted an additional 93 interviews with Black Coloradans through March 8, and 75 phone interviews with low-income individuals over age 65 across the state.

The state has deliberately pursued equity in vaccine access, and has promoted educational campaigns for groups with vaccine hesitancy– and continues to make progress on this issue. 

The state has posted the summary report.

Vaccine information is available at covid19.colorado.gov/vaccine or in Spanish at covid19.colorado.gov/vacuna. Continue to stay up to date in English and Spanish by visiting covid19.colorado.gov.

___________________________________________________________________________________________________

Una nueva encuesta muestra que el número de habitantes de Colorado que tienen intención de vacunarse contra el COVID-19 es el doble que el año pasado

REMOTO, (26 de marzo de 2021): El día de hoy, el Departamento de Salud Pública y Medio Ambiente de Colorado (CDPHE, por sus siglas en inglés) está publicando una encuesta de opinión actualizada sobre las vacunas. Al comparar esta encuesta con los datos de una encuesta anterior de septiembre de 2020, queda claro que ha habido un cambio significativo en las opiniones de los habitantes de Colorado sobre las vacunas contra el COVID-19.

Los aspectos más destacados de la encuesta incluyen un cambio significativo en el porcentaje de los habitantes de Colorado interesados en vacunarse cuando una vacuna esté disponible, con un 88% de habitantes de Colorado que ahora indican que posiblemente se vacunarán, en comparación con un 66% en septiembre:

  • En septiembre, el 32% de los encuestados dijeron que tenían la intención de vacunarse tan pronto como pudieran. Ahora, el 62% de los habitantes de Colorado ya se han vacunado (27%), o tienen la intención de vacunarse “tan pronto como [ellos] puedan (35%)”.
  • En septiembre, el 34% de los encuestados dijeron que “esperarían a ver” qué tal funcionan las vacunas. Hoy, solamente el 18% dicen que quieren “esperar a ver”.
  • En septiembre, el 34% de los encuestados dijeron que “no se vacunarían”. Ahora, el 8% “se vacunarían, pero solamente si es necesario”, mientras que el 12% “definitivamente no se vacunarían”, incluyendo a los que no pueden hacerlo por razones médicas.
  • Además, los datos muestran cambios significativos entre comunidades específicas, incluyendo a:

“Las vacunas contra el COVID-19 son seguras y efectivas, como demuestran no sólo los ensayos clínicos, sino que, a nivel nacional, muchos millones ya han recibido la vacuna”, dijo Jill Hunsaker Ryan, directora ejecutiva del CDPHE. “Cientos de miles de habitantes de Colorado ya se han inscrito para sus citas de vacunación. A medida que más y más habitantes de Colorado se vacunan, y más se entusiasman por vacunarse, estamos mucho más cerca de volver al trabajo y a la escuela, de volver a pasar tiempo con la familia y de volver a una vida más normal.”

Los datos de la encuesta son claros; incluso con este progreso, es importante seguir insistiendo en la seguridad y eficacia demostradas de las vacunas contra el COVID-19. Casi la mitad (46%) de los habitantes de Colorado tiene preguntas sobre si la vacuna los protegerá, y el 42% tiene preguntas sobre por qué la vacuna es segura.

Como parte de los esfuerzos de Vacunas para Todos del Gobernador Polis, el estado continúa trabajando para aumentar el acceso a las vacunas y para ayudar los habitantes de Colorado donde sea que se encuentren, al:

  • Coordinar clínicas comunitarias que atienden a comunidades altamente impactadas en más de 30 condados, así como en toda el área metropolitana de Denver, con planes para más. El objetivo es vacunar al 70% de los residentes elegibles en las comunidades que se encuentran en las áreas de censos más altos que tienen una alta densidad de comunidades de bajos ingresos y minorías. El estado está trabajando directamente con las organizaciones comunitarias, los proveedores, las agencias locales de salud pública y las tribus para organizar eventos y enviar las dosis directamente a los proveedores en estas áreas de censos con el fin de alcanzar la meta del Gobernador de ofrecer vacunas que salvan vidas a todos los que lo deseen.
  • Lanzar centros comunitarios de vacunación en los condados de Larimer, Pueblo, Colorado Springs, Commerce City y Grand Junction. En las próximas semanas se abrirá un centro adicional en el Ball Arena en el condado de Denver. Se espera que los seis centros comunitarios de vacunación de Vacunas para Todos administren un máximo de 6,000 dosis por día en cada centro, seis días a la semana, para un total de 36,000 dosis administradas cada semana durante todo el programa. Esto depende del suministro de vacunas que se proporcione al estado. 
  • Coordinar con United Way 211 y los proveedores de transporte para ayudar a los habitantes de Colorado con barreras de movilidad o sin vehículos personales. También estamos trabajando con el Departamento de Política y Financiación de Atención Médica de Colorado para identificar a las personas confinadas en casa que no pueden asistir a una clínica de vacunación, incluso con apoyo de transporte. En estos casos, estamos trabajando con proveedores que pueden ir a la casa de la persona para vacunarla.
  • Facilitar un programa de Campeones para la Equidad de las Vacunas para proporcionar información a las comunidades de color sobre la seguridad y la eficacia de las vacunas, así como utilizar Promotoras, proveedores de servicios y consejeros de crisis para apoyar la alfabetización sobre las vacunas. La iniciativa pretende fomentar un diálogo sostenido con las comunidades estructuralmente marginadas, particularmente las comunidades de color, sobre la vacuna, poniéndolas en contacto con trabajadores sanitarios de sus comunidades y orígenes.
  • Lanzar una línea directa de atención telefónica 7 días a la semana, 24 horas al día, que está disponible para responder preguntas en varios idiomas. El número gratuito es 1-877-CO VAX CO (1-877-268-2926).

Kupersmit Research realizó la encuesta del 17 de febrero al 1 de marzo de 2021, entrevistando a 810 participantes en línea. La empresa realizó 93 entrevistas adicionales con habitantes de Colorado de origen afroamericano hasta el 8 de marzo, y 75 entrevistas telefónicas con personas de bajos ingresos mayores de 65 años en todo el estado.

El estado ha buscado deliberadamente la equidad en el acceso a las vacunas, y ha promovido campañas educativas para los grupos de personas que tienen dudas sobre las vacunas, y continúa progresando en este tema.

El estado ha publicado el resumen del reporte.

La información sobre las vacunas está disponible en covid19.colorado.gov/vaccine o en español en covid19.colorado.gov/vacuna. Continúe manteniéndose informado en inglés y en español al visitar covid19.colorado.gov.

CDPHE: New survey shows twice as many Coloradans intend to get a COVID-19 vaccine as last year